| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date | Match? |
|---|
| Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer | [1]Beatriz Paumard-Hernández, [2]Oriol Calvete, [3]Lucia Inglada Pérez, [4]Héctor Tejero, [5]Fátima Al-Shahrour, [6]Guillermo Pita, [7]Alicia Barroso, [8]Juan Carlos Triviño, [9]Miguel Urioste, [10]Claudia Valverde, ..., [15]Cristina López, [16]Pablo Maroto, [17]Javier Sastre, [18]María José Juan Fita, [19]Ignacio Duran, ... [Full author list] | International Journal of Cancer [missing] | DOI: 10.1002/IJC.31604 [ORCID]
PubMed: 29761480 [ORCID]
| testicular cancer [missing] | 2018-08-09 | |
| Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients | [1]Enrique Gonzalez-Billalabeitia, [2]Daniel Castellano, [3]Nora Sobrevilla, [4]Josep Guma, [5]David Hervás Marín, [6]Maria I Luengo, [7]Jorge Aparicio, [8]Alfonso Sanchez-Muñoz, [9]Begoña Mellado, [10]Alberto Saenz, ..., [14]Ignacio Duran, [15]Sara Fernandez, [16]Javier Sastre, [17]Silverio Ros, [18]Pablo Maroto, ... [Full author list] | Journal of the National Cancer Institute [missing] | DOI: 10.1093/JNCI/DJW265 [ORCID]
PubMed: 28122896 [ORCID]
| venous thromboembolism [missing]; germ cell cancer [missing] | 2017-01-25 | |
| Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer | [1]Enrique González-Billalabeitia, [2]Juan Manuel Sepúlveda, [3]Pablo Maroto, [4]Jorge Aparicio, [5]Jose Angel Arranz, [6]Emilio Esteban, [7]Regina Gironés, [8]Marta López-Brea, [9]María José Mendez-Vidal, [10]Álvaro Pinto, [11]Javier Sastre, [12]Diego Soto de Prado, [13]Josefa Terrasa, [14]Sergio Vázquez, [15]Thomas Powles, [16]Jörg Beyer, [17]Daniel Castellano, [18]Xavier García Del Muro, [19]Spanish Germ Cell Cancer Group and the Spanish Oncology Genitourinary Group [Full author list] | European Urology Focus [missing] | DOI: 10.1016/J.EUF.2016.07.002 [ORCID]
PubMed: 28753776 [ORCID]
| germ cell cancer [missing] | 2016-07-18 | |
| C8-T1 Radiculopathy Due to an Intradural Extramedullary Metastasis of a Pancreatic Neuroendocrine Tumor: Case Report and Review of the Literature | [1]Santiago Cabezas-Camarero, [2]Javier Sastre, [3]María Carmen Polidura, [4]Natividad Gomez-Ruiz, [5]Issa Subhi-Issa, [6]Pedro Alonso Lera, [7]Beatriz García Paredes, [8]Eduardo Díaz-Rubio [Full author list] | Pancreas [missing] | DOI: 10.1097/MPA.0000000000000515 [ORCID]
PubMed: 27077714 [ORCID]
| neuroendocrine tumor [missing] | 2016-05-01 | |
| Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH | [1]Alejandro Forner, [2]María Reig, [3]María Varela, [4]Marta Burrel, [5]Jaime Feliu, [6]Javier Briceño, [7]Javier Sastre, [8]Luis Martí-Bonmati, [9]Josep María Llovet, [10]José Ignacio Bilbao, [11]Bruno Sangro, [12]Fernando Pardo, [13]Carmen Ayuso, [14]Concepció Bru, [15]Josep Tabernero Caturla, [16]Jordi Bruix [Full author list] | Medicina clínica [missing] | DOI: 10.1016/J.MEDCLI.2016.01.028 [ORCID]
PubMed: 26971984 [ORCID]
| | 2016-03-10 | |
| Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy | [1]Patricia Llovet, [2]Javier Sastre, [3]Julián Sanz Ortega, [4]Inmaculada Bando, [5]Milagros Ferrer, [6]Pilar García-Alfonso, [7]Olga Donnay, [8]Alfredo Carrato, [9]Ana Jiménez, [10]Enrique Aranda, [11]Ana León, [12]Cristina Grávalos, [13]Juan Carlos Cámara, [14]Jaime Feliú, [15]Bárbara Sanchíz, [16]Trinidad Caldés, [17]Eduardo Díaz-Rubio [Full author list] | Molecular Diagnosis and Therapy [missing] | DOI: 10.1007/S40291-015-0165-0 [ORCID]
PubMed: 26341080 [ORCID]
| colorectal cancer [missing]; metastatic colon cancer [missing] | 2015-12-01 | |
| Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series | [1]Javier Sastre, [2]Juan Jose Serrano, [3]Cristina Fernández Pérez, [4]Carmen Ramirez, [5]Luis Ortega, [6]Beatriz García-Paredes, [7]Juan Corona, [8]Rosario Alfonso, [9]Sofía Córdoba, [10]Eduardo Díaz-Rubio [Full author list] | Clinical Colorectal Cancer [missing] | DOI: 10.1016/J.CLCC.2015.08.001 [ORCID]
PubMed: 26385572 [ORCID]
| | 2015-08-24 | |
| Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study | [1]Alfredo Carrato, [2]Pilar García, [3]Rafael López, [4]Teresa Macarulla, [5]Fernando Rivera, [6]Javier Sastre, [7]Joana Gostkorzewicz, [8]Patricia Benedit, [9]Ferran Pérez-Alcántara [Full author list] | Expert Review of Pharmacoeconomics & Outcomes Research [missing] | DOI: 10.1586/14737167.2015.1047349 [ORCID]
PubMed: 25991037 [ORCID]
| nanoparticle [missing]; paclitaxel [missing] | 2015-05-19 | |
| A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features | [1]Ramon Salazar, [2]Jaume Capdevila, [3]Berta Laquente, [4]Jose Luis Manzano, [5]Carles Pericay, [6]Mercedes Martínez Villacampa, [7]Carlos López, [8]Ferran Losa, [9]Maria Jose Safont, [10]Auxiliadora Gómez, [11]Vicente Alonso, [12]Pilar Escudero, [13]Javier Gallego, [14]Javier Sastre, [15]Cristina Grávalos, [16]Sebastiano Biondo, [17]Amalia Palacios, [18]Enrique Aranda [Full author list] | BMC Cancer [missing] | DOI: 10.1186/S12885-015-1053-Z [ORCID]
PubMed: 25886378 [ORCID]
| bevacizumab [missing]; chemoradiotherapy [missing] | 2015-02-26 | |
| nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial | [1]David Goldstein, [2]Robert Hassan El-Maraghi, [3]Pascal Hammel, [4]Volker Heinemann, [5]Volker Kunzmann, [6]Javier Sastre, [7]Werner Scheithauer, [8]Salvatore Siena, [9]Josep Tabernero Caturla, [10]Luis Teixeira, [11]Giampaolo Tortora, [12]Jean-Luc Van Laethem, [13]Rosemary Young, [14]Darryl Neil Penenberg, [15]Brian Lu, [16]Alfredo Romano, [17]Daniel D Von Hoff [Full author list] | Journal of the National Cancer Institute [missing] | DOI: 10.1093/JNCI/DJU413 [ORCID]
PubMed: 25638248 [ORCID]
| pancreatic cancer [missing]; phase III clinical trial [missing] | 2015-01-31 | |
| Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer? | [1]Carlos Aguado, [2]Beatriz García-Paredes, [3]Miguel Jhonatan Sotelo, [4]Javier Sastre, [5]Eduardo Díaz-Rubio [Full author list] | World Journal of Gastroenterology [missing] | DOI: 10.3748/WJG.V20.I20.6092 [ORCID]
PubMed: 24876731 [ORCID]
| colorectal cancer [missing]; fluorouracil [missing]; capecitabine [missing] | 2014-05-01 | |
| Role of cetuximab in first-line treatment of metastatic colorectal cancer | [1]Miguel Jhonatan Sotelo, [2]Beatriz García-Paredes, [3]Carlos Aguado, [4]Javier Sastre, [5]Eduardo Díaz-Rubio [Full author list] | World Journal of Gastroenterology [missing] | DOI: 10.3748/WJG.V20.I15.4208 [ORCID]
PubMed: 24764659 [ORCID]
| colorectal cancer [missing]; cetuximab [missing]; colorectal carcinoma [missing]; metastatic colon cancer [missing] | 2014-04-01 | |
| Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study | [1]Marta Martín-Richard, [2]Bartomeu Massutí, [3]Eva Pineda, [4]Vicente Alonso, [5]Maribel Marmol, [6]Daniel Castellano, [7]Emilio Fonseca, [8]Antonio Galán, [9]Marta Llanos, [10]Maria Angeles Sala, [11]Carlos Pericay, [12]Fernando Rivera, [13]Javier Sastre, [14]Angel Segura, [15]Maria Quindós, [16]Pascal Maisonobe, [17]TTD (Tumores del Tracto Digestivo) Study Group [Full author list] | BMC Cancer [missing] | DOI: 10.1186/1471-2407-13-427 [ORCID]
PubMed: 24053191 [ORCID]
| multicenter clinical trial [missing] | 2013-09-20 | |
| Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab | [1]Javier Sastre, [2]Marta Vidaurreta, [3]Auxiliadora Gómez, [4]Fernando Rivera, [5]Bartomeu Massutí, [6]Margarita Reboredo López, [7]Albert Abad, [8]Manuel Gallen, [9]Manuel Benavides, [10]Enrique Aranda, [11]Eduardo Díaz Rubio, [12]Spanish Cooperative Group for the Treatment of Digestive Tumors [Full author list] | Clinical Colorectal Cancer [missing] | DOI: 10.1016/J.CLCC.2013.06.001 [ORCID]
PubMed: 24012456 [ORCID]
| colorectal cancer [missing]; bevacizumab [missing]; chemotherapy [missing]; colorectal carcinoma [missing]; metastatic colon cancer [missing] | 2013-09-05 | |
| Circulating tumor cells following first chemotherapy cycle: an early and strong predictor of outcome in patients with metastatic breast cancer | [1]Miguel Martín, [2]Sara Custodio, [3]Maria-Luisa Maestro de Las Casas, [4]José-Ángel García-Sáenz, [5]Julio-César de la Torre, [6]Jose-María Bellón-Cano, [7]Sara López-Tarruella, [8]Marta Vidaurreta-Lazaro, [9]Virginia de la Orden, [10]Yolanda Jerez, [11]Iván Márquez-Rodas, [12]Antonio Casado, [13]Javier Sastre, [14]Eduardo Díaz-Rubio [Full author list] | Oncologist [missing] | DOI: 10.1634/THEONCOLOGIST.2012-0479 [ORCID]
PubMed: 23873719 [ORCID]
| chemotherapy [missing] | 2013-07-19 | |
| Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative study | [1]Eduardo Díaz-Rubio, [2]Auxiliadora Gómez-España, [3]Bartomeu Massutí, [4]Javier Sastre, [5]Margarita Reboredo, [6]José Luis Manzano, [7]Fernando Rivera, [8]M José Safont, [9]Clara Montagut, [10]Encarnación González, [11]Manuel Benavides, [12]Eugenio Marcuello, [13]Andrés Cervantes, [14]Purificación Martínez de Prado, [15]Carlos Fernández-Martos, [16]Antonio Arrivi, [17]Inmaculada Bando, [18]Enrique Aranda, [19]Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) [Full author list] | PLOS One [missing] | DOI: 10.1371/JOURNAL.PONE.0047345 [ORCID]
PubMed: 23174912 [ORCID]
| colorectal cancer [missing]; bevacizumab [missing]; chemotherapy [missing]; colorectal carcinoma [missing]; metastatic colon cancer [missing] | 2012-10-12 | |
| Sorafenib for non-selected patient population with advanced hepatocellular carcinoma: efficacy and safety data according to liver function | [1]Jon Zugazagoitia, [2]Aránzazu Manzano, [3]Javier Sastre, [4]Jose María Ladero, [5]Javier Puente, [6]Eduardo Díaz-Rubio, [7]Aranzazu Manzano [Full author list] | Clinical and Translational Oncology [missing] | DOI: 10.1007/S12094-012-0902-3 [ORCID]
PubMed: 22875650 [ORCID]
| patient [missing]; hepatocellular carcinoma [missing] | 2012-08-09 | |
| Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior | [1]Beatriz Perez-Villamil, [2]Alejandro Romera-Lopez, [3]Susana Hernandez-Prieto, [4]Guillermo H López-Campos, [5]Antonio Calles, [6]Jose-Antonio Lopez-Asenjo, [7]Julian Sanz-Ortega, [8]Cristina Fernández Pérez, [9]Javier Sastre, [10]Rosario Alfonso, [11]Trinidad Caldes, [12]Fernando Martin-Sanchez, [13]Eduardo Díaz-Rubio [Full author list] | BMC Cancer [missing] | DOI: 10.1186/1471-2407-12-260 [ORCID]
PubMed: 22712570 [ORCID]
| colon cancer [missing] | 2012-06-19 | |
| Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study | [1]Javier Sastre, [2]M Luisa Maestro, [3]Auxiliadora Gómez-España, [4]Fernando Rivera, [5]Manuel Valladares, [6]Bartomeu Massuti, [7]Manuel Benavides, [8]Manuel Gallén, [9]Eugenio Marcuello, [10]Albert Abad, [11]Antonio Arrivi, [12]Carlos Fernández-Martos, [13]Encarnación González, [14]Josep Tabernero Caturla, [15]Marta Vidaurreta, [16]Enrique Aranda, [17]Eduardo Díaz-Rubio [Full author list] | Oncologist [missing] | DOI: 10.1634/THEONCOLOGIST.2012-0048 [ORCID]
PubMed: 22643538 [ORCID]
| colorectal cancer [missing]; bevacizumab [missing]; chemotherapy [missing]; cell line [missing]; colorectal carcinoma [missing]; metastatic colon cancer [missing] | 2012-05-29 | |
| First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study | [1]Javier Sastre, [2]Cristina Grávalos, [3]Fernando Rivera, [4]Bartomeu Massuti, [5]Manuel Valladares-Ayerbes, [6]Eugenio Marcuello, [7]José L Manzano, [8]Manuel Benavides, [9]Manuel Hidalgo, [10]Eduardo Díaz-Rubio, [11]Enrique Aranda [Full author list] | Oncologist [missing] | DOI: 10.1634/THEONCOLOGIST.2011-0406 [ORCID]
PubMed: 22363067 [ORCID]
| colorectal cancer [missing]; capecitabine [missing]; cetuximab [missing]; colorectal carcinoma [missing] | 2012-02-23 | |
| First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study | [1]Eduardo Díaz-Rubio, [2]Auxiliadora Gómez-España, [3]Bartomeu Massutí, [4]Javier Sastre, [5]Albert Abad, [6]Manuel Valladares, [7]Fernando Rivera, [8]Maria J Safont, [9]Purificación Martínez de Prado, [10]Manuel Gallén, ... [Full author list] | Oncologist [missing] | DOI: 10.1634/THEONCOLOGIST.2011-0249 [ORCID]
PubMed: 22234633 [ORCID]
| patient [missing]; colorectal cancer [missing]; bevacizumab [missing]; colorectal carcinoma [missing]; metastatic colon cancer [missing] | 2012-01-10 | |
| Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines. | [1]Jaime Feliu, [2]Javier Sastre, [3]Joan Maurel, [4]Dolores Isla [Full author list] | Clinical and Translational Oncology [missing] | DOI: 10.1007/S12094-011-0694-X [ORCID]
PubMed: 21821487 [ORCID]
| | 2011-08-01 | |
| A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome | [1]Daniela Caronia, [2]Miguel Martin, [3]Javier Sastre, [4]Julio-Cesar de la Torre-Montero, [5]José Angel García-Sáenz, [6]Maria R Alonso, [7]Leticia T Moreno, [8]Guillermo Pita, [9]Eduardo Díaz-Rubio, [10]Javier Benítez, [11]Anna González-Neira [Full author list] | Clinical Cancer Research [missing] | DOI: 10.1158/1078-0432.CCR-10-1741 [ORCID]
PubMed: 21325291 [ORCID]
| | 2011-02-16 | |
| Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register | [1]Javier Puente, [2]Sara López-Tarruella, [3]Amparo Ruiz, [4]Ana Lluch, [5]Miguel Pastor, [6]Emilio Alba, [7]Juan de la Haba, [8]Manuel Ramos, [9]Luis Cirera, [10]Antonio Antón, [11]Antoni Llombart, [12]Arrate Plazaola, [13]Antonio Fernández-Aramburo, [14]Javier Sastre, [15]Eduardo Díaz-Rubio, [16]Miguel Martin [Full author list] | Breast Cancer Research and Treatment [missing] | DOI: 10.1007/S10549-009-0687-4 [ORCID]
PubMed: 20063196 [ORCID]
| patient [missing] | 2010-01-10 | |
| Circulating tumor cells in solid tumor in metastatic and localized stages | [1]Luisa M Maestro, [2]Javier Sastre, [3]Sara Rafael, [4]Silvia Veganzones, [5]Marta Vidaurreta, [6]Miguel Martin, [7]Carlos Olivier, [8]Virginia De La Orden Garcia, [9]Jose A Garcia-Saenz, [10]Rosario Alfonso, [11]Manuel Arroyo, [12]Eduardo Díaz-Rubio [Full author list] | Anticancer Research [missing] | PubMed: 20032444 [ORCID]
| | 2009-11-01 | |
| Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis | [1]Miguel Martin, [2]Jose A Garcia-Saenz, [3]Maria Luisa Maestro De las Casas, [4]Marta Vidaurreta, [5]Javier Puente, [6]Silvia Veganzones, [7]Laura Rodríguez-Lajusticia, [8]Virginia De La Orden Garcia, [9]Belén Oliva-Urcia, [10]Julio-César De la Torre, [11]Sara López-Tarruella, [12]Antonio Casado, [13]Javier Sastre, [14]Eduardo Díaz-Rubio [Full author list] | Anticancer Research [missing] | PubMed: 19846970 [ORCID]
| metastatic breast cancer [missing] | 2009-10-01 | |
| Second-line therapy for advanced pancreatic cancer: a review of the literature and future directions | [1]Ana Custodio, [2]Javier Puente, [3]Javier Sastre, [4]Eduardo Díaz-Rubio [Full author list] | Cancer Treatment Reviews [missing] | DOI: 10.1016/J.CTRV.2009.08.012 [ORCID]
PubMed: 19758760 [ORCID]
| pancreatic cancer [missing] | 2009-09-15 | |
| Circulating tumour cells in locally advanced breast cancer | [1]Jose A Garcia-Saenz, [2]Miguel Martin, [3]María Luisa Maestro, [4]Marta Vidaurreta, [5]Silvia Veganzones, [6]Sara Rafael, [7]Antonio Casado, [8]Jana Bobokova, [9]Javier Sastre, [10]Virginia De La Orden Garcia, [11]Manuel Arroyo, [12]Eduardo Díaz-Rubio [Full author list] | Clinical and Translational Oncology [missing] | DOI: 10.1007/S12094-009-0400-4 [ORCID]
PubMed: 19661030 [ORCID]
| | 2009-08-01 | |
| [Diagnosis and treatment of hepatocellular carcinoma]. | [1]Alejandro Forner, [2]Carmen Ayuso, [3]Carmen Ayuso, [4]Maria Isabel Real Navacerrada, [5]Javier Sastre, [6]Ricardo Robles, [7]Bruno Sangro, [8]María Varela, [9]Manuel de la Mata, [10]María Buti, [11]Luis Martí-Bonmatí, [12]Concepció Bru, [13]Josep Tabernero Caturla, [14]Josep M. Llovet, [15]Jordi Bruix [Full author list] | Medicina clínica [missing] | DOI: 10.1016/J.MEDCLI.2008.11.024 [ORCID]
PubMed: 19248879 [ORCID]
| | 2009-02-14 | |
| Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study | [1]Javier Sastre, [2]Enrique Aranda, [3]Bartomeu Massutí, [4]Josep Tabernero Caturla, [5]Manuel Chaves, [6]Albert Abad, [7]Alfredo Carrato, [8]Juan José Reina, [9]Bernardo Queralt, [10]Auxiliadora Gómez-España, [11]Encarnación González-Flores, [12]Fernando Rivera, [13]Ferrán Losa, [14]Teresa García, [15]Pedro Sanchez-Rovira, [16]Inmaculada Maestu, [17]Eduardo Díaz-Rubio [Full author list] | Critical Reviews in Oncology Hematology [missing] | DOI: 10.1016/J.CRITREVONC.2008.11.002 [ORCID]
PubMed: 19111473 [ORCID]
| colorectal cancer [missing]; oxaliplatin [missing]; chemotherapy [missing] | 2008-12-25 | |
| Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study | [1]Xavier Garcia-del-Muro, [2]Pablo Maroto, [3]Josep Gumà, [4]Javier Sastre, [5]Marta López Brea, [6]José A Arranz, [7]Nuria Lainez, [8]Diego Soto de Prado, [9]Jorge Aparicio, [10]Josep M Piulats, [11]Xavier Pérez, [12]Josep R Germá-Lluch [Full author list] | Journal of Clinical Oncology [missing] | DOI: 10.1200/JCO.2007.15.9103 [ORCID]
PubMed: 18936476 [ORCID]
| chemotherapy [missing]; germ cell cancer [missing] | 2008-10-20 | |
| Irinotecan in the treatment of elderly patients with advanced colorectal cancer | [1]Javier Sastre, [2]Javier Puente, [3]Jose A García-Saenz, [4]Eduardo Díaz-Rubio [Full author list] | Critical Reviews in Oncology Hematology [missing] | DOI: 10.1016/J.CRITREVONC.2008.05.008 [ORCID]
PubMed: 18722784 [ORCID]
| colorectal cancer [missing]; irinotecan [missing] | 2008-08-23 | |
| Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer | [1]Eva Martinez-Balibrea, [2]Albert Abad, [3]Enrique Aranda, [4]Javier Sastre, [5]Jose Luis Manzano, [6]Eduardo Díaz-Rubio, [7]Auxiliadora Gómez-España, [8]Jorge Aparicio, [9]Teresa García, [10]Inmaculada Maestu, [11]Anna Martínez-Cardús, [12]Anna Martínez-Cardús, [13]Alba Ginés, [14]Elisabet Guino, [15]Spanish Group for the Treatment of Digestive Tumours [Full author list] | European Journal of Cancer [missing] | DOI: 10.1016/J.EJCA.2008.03.025 [ORCID]
PubMed: 18448328 [ORCID]
| colorectal cancer [missing]; fluorouracil [missing]; capecitabine [missing]; oxaliplatin [missing]; chemotherapy [missing] | 2008-04-28 | |
| Detection and quantification of circulating tumor cells in peripheral blood in patients with colon cancer | [1]Marta Vidaurreta, [2]Javier Sastre, [3]María Teresa Sanz-Casla, [4]María Luisa Maestro, [5]Sara Rafael, [6]Eduardo Díaz-Rubio [Full author list] | Medicina clínica [missing] | DOI: 10.1157/13109544 [ORCID]
PubMed: 17910847 [ORCID]
| | 2007-09-01 | |
| Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial | [1]Eduardo Díaz-Rubio, [2]Josep Tabernero Caturla, [3]Auxiliadora Gómez-España, [4]Bartomeu Massutí, [5]Javier Sastre, [6]Manuel Chaves, [7]Alberto Abad, [8]Alfredo Carrato, [9]Bernardo Queralt, [10]Juan José Reina, [11]Joan Maurel, [12]Encarnación González-Flores, [13]Jorge Aparicio, [14]Fernando Rivera, [15]Ferrán Losa, [16]Enrique Aranda, [17]Spanish Cooperative Group for the Treatment of Digestive Tumors Trial [Full author list] | Journal of Clinical Oncology [missing] | DOI: 10.1200/JCO.2006.09.8467 [ORCID]
PubMed: 17548839 [ORCID]
| colorectal cancer [missing]; fluorouracil [missing]; capecitabine [missing]; oxaliplatin [missing]; colorectal carcinoma [missing]; phase III clinical trial [missing]; metastatic colon cancer [missing] | 2007-06-04 | |
| Circulating tumoral cells lack circadian-rhythm in hospitalized metastasic breast cancer patients | [1]Jose A Garcia-Saenz, [2]Miguel Martin, [3]Marisa Maestro, [4]Marta Vidaurreta, [5]Silvia Veganzones, [6]Laura Villalobos, [7]Laura Rodríguez-Lajusticia, [8]Sara Rafael, [9]María Teresa Sanz-Casla, [10]Antonio Casado, [11]Javier Sastre, [12]Manuel Arroyo, [13]Eduardo Díaz-Rubio [Full author list] | Clinical and Translational Oncology [missing] | DOI: 10.1007/S12094-006-0139-0 [ORCID]
PubMed: 17134972 [ORCID]
| circadian rhythm [missing]; hospitalization [missing] | 2006-11-01 | |
| UFT in combination with oxaliplatin: clinical phase I study in patients with advanced or metastatic solid tumors | [1]Javier Sastre, [2]Enrique Aranda, [3]Albert Abad, [4]Javier Gallego, [5]José Luis Manzano, [6]Auxiliadora Gómez, [7]Alfredo Carrato, [8]Eva López, [9]Eduardo Díaz-Rubio, [10]TTD Group [Full author list] | Anti-Cancer Drugs [missing] | DOI: 10.1097/01.CAD.0000205032.31708.DE [ORCID]
PubMed: 16549999 [ORCID]
| oxaliplatin [missing] | 2006-04-01 | |
| Chemotherapy for gastric cancer | [1]Javier Sastre, [2]Jose A Garcia-Saenz, [3]Eduardo Díaz-Rubio [Full author list] | World Journal of Gastroenterology [missing] | DOI: 10.3748/WJG.V12.I2.204 [ORCID]
PubMed: 16482619 [ORCID]
| chemotherapy [missing] | 2006-01-01 | |
| Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study | [1]Emilio Fonseca, [2]Juan José Grau, [3]Javier Sastre, [4]Jesús María García-Gómez, [5]Antonio Rueda, [6]Miguel Pastor, [7]Miguel A Lara, [8]Marta Navalón, [9]Alfonso Berrocal, [10]José Luis Tisaire, [11]Juan Jesús Cruz [Full author list] | European Journal of Cancer [missing] | DOI: 10.1016/J.EJCA.2005.02.019 [ORCID]
PubMed: 15908196 [ORCID]
| head and neck squamous cell carcinoma [missing] | 2005-06-01 | |
| Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors study | [1]Javier Sastre, [2]Eugenio Marcuello, [3]Bartomeu Masutti, [4]Matilde Navarro, [5]Silvia Gil, [6]Antonio Antón, [7]Albert Abad, [8]Enrique Aranda, [9]Joan Maurel, [10]Manuel Valladares, [11]Inmaculada Maestu, [12]Alfredo Carrato, [13]José María Vicent, [14]Eduardo Díaz-Rubio, [15]Cooperative Group for the Treatment of Digestive Tumors [Full author list] | Journal of Clinical Oncology [missing] | DOI: 10.1200/JCO.2005.03.004 [ORCID]
PubMed: 15908665 [ORCID]
| colorectal cancer [missing]; fluorouracil [missing]; irinotecan [missing]; chemotherapy [missing]; metastatic colon cancer [missing] | 2005-05-01 | |
| Two consecutive phase II trials of biweekly oxaliplatin plus weekly 48-hour continuous infusion of nonmodulated high-dose 5-fluorouracil as first-line treatment for advanced colorectal cancer | [1]Albert Abad, [2]Alfredo Carrato, [3]Matilde Navarro, [4]Javier Sastre, [5]Andrés Cervantes, [6]Antonio Antón, [7]Mercedes Martinez-Villacampa, [8]Eugenio Marcuello, [9]Bartomeo Massutí, [10]Enrique Aranda, [11]José Luis Manzano, [12]José Luis Guallar, [13]Eduardo Díaz-Rubio [Full author list] | Clinical Colorectal Cancer [missing] | DOI: 10.3816/CCC.2005.N.010 [ORCID]
PubMed: 15807931 [ORCID]
| colorectal cancer [missing]; fluorouracil [missing]; oxaliplatin [missing]; phase II clinical trial [missing] | 2005-03-01 | |
| A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours | [1]Javier Sastre, [2]Luis Paz-Ares, [3]Antonio Carcas, [4]Rosario Alfonso, [5]Cristina Grávalos, [6]Jesus Frías, [7]Pedro Guerra, [8]Linda Pronk, [9]Hernán Cortés-Funes, [10]Eduardo Díaz-Rubio [Full author list] | Cancer Chemotherapy and Pharmacology [missing] | DOI: 10.1007/S00280-004-0915-X [ORCID]
PubMed: 15818508 [ORCID]
| fluorouracil [missing]; irinotecan [missing] | 2004-10-26 | |
| 5-fluorouracil as a protracted continuous infusion plus irinotecan (CPT-11) in patients with advanced colorectal cancer treated with fluoropyrimidine-based regimens as first line | [1]Javier Sastre, [2]Rosario Alfonso, [3]José Antonio Macías, [4]Isabel Manrique, [5]Luis Flores, [6]Eduardo Díaz-Rubio [Full author list] | Anti-Cancer Drugs [missing] | DOI: 10.1097/00001813-200308000-00006 [ORCID]
PubMed: 12960738 [ORCID]
| colorectal cancer [missing]; fluorouracil [missing]; irinotecan [missing] | 2003-08-01 | |